Yoshiyuki Fujiwara

Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway

Rie Hamano, Hiroshi Miyata, Makoto Yamasaki et al. · Clinical Cancer Research · 2011 · 245 citations · Full text

Medicine, Molecular Biology, Oncology +17

Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy

Hiroshi Miyata, Akiko Yoshioka, Makoto Yamasaki et al. · Cancer · 2009 · 133 citations · Full text

Medicine, Oncology, Surgery +17

Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients

Masaaki Motoori, Masahiko Yano, Hiroshi Miyata et al. · Clinical Nutrition · 2015 · 127 citations

Medicine, Oncology, Chemotherapy +8

Accumulation of genetic changes during development and progression of hepatocellular carcinoma: Loss of heterozygosity on chromosome arm Ip occurs at an early stage of hepatocarcinogenesis

Tamobu Kuroki, Yoshiyuki Fujiwara, Eiju Tsuchiya et al. · Genes Chromosomes and Cancer · 1995 · 126 citations

Medicine, Genetics, Oncology +11

Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients

Yuichiro Hiura, Shuji Takiguchi, Kazuyoshi Yamamoto et al. · Cancer · 2012 · 125 citations · Full text

Medicine, Oncology, Pharmacology +15